150 related articles for article (PubMed ID: 2438548)
1. [Basedow's disease: surgery, the choice treatment].
Chiampo L
Minerva Endocrinol; 1987; 12(1):49-53. PubMed ID: 2438548
[No Abstract] [Full Text] [Related]
2. [Treatment of Basedow's disease].
Bürgi H
Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
[No Abstract] [Full Text] [Related]
3. [Anesthesia in surgery of Basedow's disease].
Hugon S; Pierrot M; Blaise M; Gabry AL; Cupa M
Cah Anesthesiol; 1984 Mar; 32(2):107-11. PubMed ID: 6085025
[TBL] [Abstract][Full Text] [Related]
4. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
5. [Effect of radical treatment of Basedow's disease on the ocular symptoms].
Lederer J
Ann Endocrinol (Paris); 1974; 35(1):79-81. PubMed ID: 4138226
[No Abstract] [Full Text] [Related]
6. [Current concepts in the treatment of Basedow's disease].
Jaffiol C; Baldet L
Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
[No Abstract] [Full Text] [Related]
7. [Hyperthyreosis in Basedow's disease].
Välimäki MJ
Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
[No Abstract] [Full Text] [Related]
8. [The ocular risks of treatment of Basedow's disease (author's transl)].
Mornex R; Pousset G; Guinet P
Ann Endocrinol (Paris); 1974; 35(1):74-8. PubMed ID: 4138066
[No Abstract] [Full Text] [Related]
9. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
Rasmussen AK; Feldt-Rasmussen UF
Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
[No Abstract] [Full Text] [Related]
10. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)].
Blondeau P; Wolfeler L; Rene L
Ann Chir; 1978 Dec; 32(10):779-87. PubMed ID: 86322
[No Abstract] [Full Text] [Related]
12. [The pharmacological therapy of Basedow's disease].
Lazzarin M; Segattini L; Benati F
Recenti Prog Med; 1993 Oct; 84(10):698-708. PubMed ID: 7694335
[TBL] [Abstract][Full Text] [Related]
13. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
14. [Basedow's disease].
Shizume K
Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
[No Abstract] [Full Text] [Related]
15. [Therapy of Basedow's disease].
Burger AG
Schweiz Rundsch Med Prax; 1988 Feb; 77(7):143-5. PubMed ID: 2451854
[No Abstract] [Full Text] [Related]
16. Surgery for hyperthyroidism: indications, pretreatment, operative strategy and results.
Roeher HD; Wahl R; Goretzki P; Branscheid D
Ann Chir Gynaecol; 1983; 72(3):101-4. PubMed ID: 6194731
[TBL] [Abstract][Full Text] [Related]
17. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
18. [Drug treatment of Graves' ophthalmopathy].
Prummel MF; Wiersinga WM
Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
[No Abstract] [Full Text] [Related]
19. Antithyroid drugs.
Nebesio TD; Eugster EA
N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15926207
[No Abstract] [Full Text] [Related]
20. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
